LEXICON PHARMACEUTICALS, INC. Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LEXICON PHARMACEUTICALS, INC. for March 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 19,750 | 0 | 59,250 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 17,500 | 0 | 35,000 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 13,000 | 0 | 13,000 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 0.94 | 18,266 | 17,170 | 58,767 | 77 K to 58.8 K (-23.71 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 19,750 | 0 | 77,033 | 57.3 K to 77 K (+34.48 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 17,500 | 0 | 57,283 | 39.8 K to 57.3 K (+43.99 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 13,000 | 0 | 39,783 | 26.8 K to 39.8 K (+48.54 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | NORTHCOTT JOHN | VP, Marketing, Comm ... | Option Exercise | M | 0.00 | 11,250 | 0 | 33,750 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | NORTHCOTT JOHN | VP, Marketing, Comm ... | Payment of Exercise | F | 0.94 | 3,015 | 2,834 | 8,235 | 11.3 K to 8.2 K (-26.80 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | NORTHCOTT JOHN | VP, Marketing, Comm ... | Buy | M | 0.00 | 11,250 | 0 | 11,250 | 0 to 11.3 K |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 18,750 | 0 | 56,250 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 16,500 | 0 | 33,000 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 17,500 | 0 | 17,500 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 16,250 | 0 | 0 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Payment of Exercise | F | 0.94 | 25,318 | 23,799 | 190,032 | 215.4 K to 190 K (-11.76 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 18,750 | 0 | 215,350 | 196.6 K to 215.4 K (+9.54 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 16,500 | 0 | 196,600 | 180.1 K to 196.6 K (+9.16 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 17,500 | 0 | 180,100 | 162.6 K to 180.1 K (+10.76 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 16,250 | 0 | 162,600 | 146.4 K to 162.6 K (+11.10 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 9,375 | 0 | 28,125 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,000 | 0 | 12,000 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,750 | 0 | 6,750 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 0.94 | 9,041 | 8,499 | 82,225 | 91.3 K to 82.2 K (-9.91 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 9,375 | 0 | 91,266 | 81.9 K to 91.3 K (+11.45 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,000 | 0 | 81,891 | 75.9 K to 81.9 K (+7.91 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,750 | 0 | 75,891 | 69.1 K to 75.9 K (+9.76 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 7,500 | 0 | 69,141 | 61.6 K to 69.1 K (+12.17 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 20,500 | 0 | 61,500 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 17,000 | 0 | 34,000 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 19,500 | 0 | 19,500 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 18,750 | 0 | 0 | |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 0.94 | 20,718 | 19,475 | 204,821 | 225.5 K to 204.8 K (-9.19 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 20,500 | 0 | 225,539 | 205 K to 225.5 K (+10.00 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 17,000 | 0 | 205,039 | 188 K to 205 K (+9.04 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 19,500 | 0 | 188,039 | 168.5 K to 188 K (+11.57 %) |
Mar 03 2015 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 18,750 | 0 | 168,539 | 149.8 K to 168.5 K (+12.52 %) |